BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32213530)

  • 1. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years.
    Son J; Carr C; Yao M; Radeva M; Priyadarshini A; Marquard J; Michener CM; AlHilli M
    Int J Gynecol Cancer; 2020 May; 30(5):631-639. PubMed ID: 32213530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    Chung YS; Woo HY; Lee JY; Park E; Nam EJ; Kim S; Kim SW; Kim YT
    Am J Obstet Gynecol; 2021 Apr; 224(4):370.e1-370.e13. PubMed ID: 33039397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers.
    Kim SR; Pina A; Albert A; McAlpine JN; Wolber R; Gilks B; Carey MS; Kwon JS
    Int J Gynecol Cancer; 2020 Jun; 30(6):783-788. PubMed ID: 32354793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.
    Lee TS; Lee JY; Kim JW; Oh S; Seong SJ; Lee JM; Kim TJ; Cho CH; Kim SM; Park CY
    Gynecol Oncol; 2013 Nov; 131(2):289-93. PubMed ID: 23994534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study.
    Lyu T; Guo L; Chen X; Jia N; Gu C; Zhu M; Zhao Y; Liu X; Feng W
    J Int Med Res; 2019 Jun; 47(6):2492-2498. PubMed ID: 31020889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
    Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
    Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
    Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
    J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
    Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
    Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
    Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
    Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
    Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgery.
    Chambers LM; Carr C; Freeman L; Jernigan AM; Michener CM
    Am J Obstet Gynecol; 2019 Sep; 221(3):243.e1-243.e11. PubMed ID: 31075245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
    Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
    PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer.
    Jorgensen K; Meernik C; Wu CF; Murphy CC; Baker VL; Jarmon P; Brady PC; Nitecki R; Nichols HB; Rauh-Hain JA
    Obstet Gynecol; 2023 Feb; 141(2):341-353. PubMed ID: 36649345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
    Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
    Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Characteristics and Prognostic Factors of Synchronous Endometrial and Ovarian Cancers-A Single-Institute Review of 43 Cases.
    Jain V; Sekhon R; Pasricha S; Giri S; Modi KB; Shrestha E; Ram D; Rawal S
    Int J Gynecol Cancer; 2017 Jun; 27(5):938-946. PubMed ID: 28498249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.